HAEMONETICS CORP — Director's Dealing 2011

Nov 1, 2011

SEC Form 4/A — Form 4/A

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2011-10-26

Reporting Person: White Jonathan (VP Research and Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-10-25	Common Stock	A	1956.0	$0.01	Acquired	10680.0	Direct

Footnotes

F1: Restricted Stock Unit Grant which vest 25% per year over 4 years following the grant date. Grant was made under 2005 Long Term Incentive Compensation Plan.

F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.